Judith A. Racoosin

Advancing the Science for Active Surveillance: Rationale and Design for the Observational Medical Outcomes Partnership

Paul Stang, Patrick Ryan, Judith A. Racoosin et al. · Annals of Internal Medicine · 2010 · 462 citations

Pharmacy, Health Informatics, Health Policy +16

The U.S. Food and Drug Administration's Mini‐Sentinel program: status and direction

Richard Platt, Ryan M. Carnahan, Jeffrey S. Brown et al. · Pharmacoepidemiology and Drug Safety · 2012 · 290 citations · Full text

Computing, Biomedical Informatics, Health Informatics +17

Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership

Patrick Ryan, David Madigan, Paul Stang et al. · Statistics in Medicine · 2012 · 186 citations

Public Health, Biostatistics, Electronic Health Records +16

The US Food and Drug Administration's Sentinel Initiative: Expanding the horizons of medical product safety

Melissa A. Robb, Judith A. Racoosin, Rachel E. Sherman et al. · Pharmacoepidemiology and Drug Safety · 2012 · 121 citations · Full text

Pharmacy, Pharmaceutical Policy, Food Safety +16

New Evidence about an Old Drug — Risk with Codeine after Adenotonsillectomy

Judith A. Racoosin, David W. Roberson, Michael Pacanowski et al. · New England Journal of Medicine · 2013 · 99 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12